Wade Aubry, MD

Dr. Wade Aubry is Clinical Professor of Medicine at UCSF, and he has been affiliated with IHPS since 1997. His career has included varied roles and settings as a clinician, medical director, health policy researcher, teacher, and consultant. He is a practicing internist and endocrinologist, and he has served as Chief of Staff for Saint Francis Hospital in SF, Medicare Medical Director for No. California, SVP and Chief Medical Officer for Blue Shield of California, VP for the Lewin Group, and as a national medical director for the Blue Cross Blue Shield Association, where he was Chair of its TEC Assessment Committee. Dr. Aubry has also served on numerous state and national health care advisory panels for the CMA, ICER, CMS, AHRQ, NIH, IOM, and NCQA related to technology assessment and Medicare coverage, evidence-based medicine, clinical trials, and health care quality. Currently, he is a member of the National Advisory Board for ICER and the NCQA Geriatrics Measurement Advisory Panel, which develops quality measures for Medicare Advantage Plans.

At UCSF, Dr. Aubry’s research interests and publications focus on health care quality, technology assessment and adoption, Medicare and health insurance coverage, and independent reviews of coverage denials. He is co-author of a comprehensive case study of a failed cancer treatment, False Hope: Bone Marrow Transplantation for Breast Cancer, Oxford University Press, 2007. He is an active member of the UCSF Health Technology Assessment Program (HTAP) Committee, which reviews and approves new clinical technologies for adoption at UCSF. Formerly, he was on the Faculty Task Force for the California Health Benefits Review Program (CHBRP) and President of the UCSF Association of the Clinical Faculty. He has also taught 3rd and 4th year medical students in clinical medicine and health policy intercessions over many years.